Edesa Biotech Management
Management criteria checks 4/4
Edesa Biotech's CEO is Par Nijhawan, appointed in Jun 2019, has a tenure of 4.83 years. total yearly compensation is $549.56K, comprised of 62.1% salary and 37.9% bonuses, including company stock and options. directly owns 13.27% of the company’s shares, worth $1.91M. The average tenure of the management team and the board of directors is 4.8 years and 4.8 years respectively.
Key information
Par Nijhawan
Chief executive officer
US$549.6k
Total compensation
| CEO salary percentage | 62.1% |
| CEO tenure | 4.8yrs |
| CEO ownership | 13.3% |
| Management average tenure | 4.8yrs |
| Board average tenure | 4.8yrs |
Recent management updates
Recent updates
Edesa Biotech (NASDAQ:EDSA) Will Have To Spend Its Cash Wisely
Aug 04
We're Keeping An Eye On Edesa Biotech's (NASDAQ:EDSA) Cash Burn Rate
Mar 10Edesa shares jump ~11%, says monoclonal antibody cuts risk of death due to COVID by 84%
Sep 30Edesa Biotech (NASDAQ:EDSA) Is In A Good Position To Deliver On Growth Plans
Sep 23Edesa says mid-stage trial for anti-allergic cream reached full enrollment
Sep 07Edesa Biotech GAAP EPS of -$0.37 beats by $0.06
Aug 12Companies Like Edesa Biotech (NASDAQ:EDSA) Can Afford To Invest In Growth
May 16Edesa Biotech: Leader In Developing Treatments For COVID-19 And ACD
Apr 18Here's Why We're A Bit Worried About Edesa Biotech's (NASDAQ:EDSA) Cash Burn Situation
Dec 08Edesa Biotech Reports Positive Phase 2 Data In Critically-Severe COVID Patients
Sep 22Here's Why We're A Bit Worried About Edesa Biotech's (NASDAQ:EDSA) Cash Burn Situation
Aug 27Edesa Biotech soars 10% on favorable DSMB review of COVID-19 study
Jun 18Is Edesa Biotech (NASDAQ:EDSA) In A Good Position To Deliver On Growth Plans?
Apr 13Director Frank Oakes Just Sold A Bunch Of Shares In Edesa Biotech, Inc. (NASDAQ:EDSA)
Feb 19Edesa Biotech receives C$14M for COVID-19 study
Feb 02Edesa Biotech (NASDAQ:EDSA) Is In A Good Position To Deliver On Growth Plans
Dec 08
Edesa Biotech EPS misses by $0.04, beats on revenue
Dec 07Edesa Biotech's lead asset mid-stage dermatitis study achieves 50% enrollment
Nov 03CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -US$8m |
| Sep 30 2023 | US$550k | US$341k | -US$8m |
| Jun 30 2023 | n/a | n/a | -US$9m |
| Mar 31 2023 | n/a | n/a | -US$13m |
| Dec 31 2022 | n/a | n/a | -US$16m |
| Sep 30 2022 | US$602k | US$326k | -US$18m |
| Jun 30 2022 | n/a | n/a | -US$18m |
| Mar 31 2022 | n/a | n/a | -US$17m |
| Dec 31 2021 | n/a | n/a | -US$15m |
| Sep 30 2021 | US$1m | US$315k | -US$13m |
| Jun 30 2021 | n/a | n/a | -US$12m |
| Mar 31 2021 | n/a | n/a | -US$9m |
| Dec 31 2020 | n/a | n/a | -US$8m |
| Sep 30 2020 | US$411k | US$300k | -US$6m |
| Jun 30 2020 | n/a | n/a | -US$5m |
| Mar 31 2020 | n/a | n/a | -US$5m |
| Dec 31 2019 | n/a | n/a | -US$4m |
| Sep 30 2019 | US$165k | US$105k | -US$3m |
| Jun 30 2019 | n/a | n/a | -US$3m |
| Mar 31 2019 | n/a | n/a | -US$2m |
| Dec 31 2018 | US$61k | US$27k | -US$2m |
Compensation vs Market: Par's total compensation ($USD549.56K) is about average for companies of similar size in the US market ($USD668.06K).
Compensation vs Earnings: Par's compensation has been consistent with company performance over the past year.
CEO
Par Nijhawan (52 yo)
4.8yrs
Tenure
US$549,561
Compensation
Dr. Pardeep Nijhawan, also known as Par, M.D., FRCPC, AGAF serves as Chief Executive Officer, Company secretary and Director at Edesa Biotech, Inc. since June 7, 2019 and having previously founded and led...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, Company Secretary & Director | 4.8yrs | US$549.56k | 13.27% $ 1.9m | |
| President | 4.8yrs | US$488.76k | 0.14% $ 19.5k | |
| Chief Financial Officer | less than a year | US$463.17k | 0.18% $ 25.8k |
4.8yrs
Average Tenure
46yo
Average Age
Experienced Management: EDSA's management team is considered experienced (4.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, Company Secretary & Director | 4.8yrs | US$549.56k | 13.27% $ 1.9m | |
| Independent Director | less than a year | US$30.81k | 0.00090% $ 129.3 | |
| Independent Director | 4.8yrs | US$85.47k | 0.064% $ 9.2k | |
| Independent Director | less than a year | US$28.13k | 0.081% $ 11.7k | |
| Independent Director | 14yrs | US$61.68k | 0.36% $ 52.1k | |
| Independent Director | less than a year | US$29.20k | 0.014% $ 2.1k | |
| Independent Chairman of the Board | 4.8yrs | US$67.83k | 0.016% $ 2.3k |
4.8yrs
Average Tenure
56yo
Average Age
Experienced Board: EDSA's board of directors are considered experienced (4.8 years average tenure).